Michael Sweeten

Michael Sweeten is a finance professional with extensive experience in the biotechnology and defense sectors. Currently serving as a Senior Finance Manager at Day One Biopharmaceuticals since July 2023, Michael previously held similar roles at Aeglea BioTherapeutics, where tenure lasted from December 2021 to July 2023. Prior to this, Michael worked as a Financial Analyst at BAE Systems between August 2020 and December 2021. Academic credentials include a Bachelor of Science in Finance from the University of Arizona's Eller College of Management, earned between 2016 and 2020.